Switch theme
Sign up to access all valuation multiples
UK-based Advanced Medical Solutions was founded in 1991 to design, develop, and manufacture advanced wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The firm derives approximately 60% of total revenue from branded products, with nonbranded contributing 40%.
1993
769
LTM Revenue $248M
LTM EBITDA $55.4M
$597M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Advanced Medical Solutions Group has a last 12-month revenue of $248M and a last 12-month EBITDA of $55.4M.
In the most recent fiscal year, Advanced Medical Solutions Group achieved revenue of $163M and an EBITDA of $41.6M.
Advanced Medical Solutions Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Advanced Medical Solutions Group valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $160M | $163M | XXX | XXX | XXX |
| Gross Profit | $78.6M | $94.5M | XXX | XXX | XXX |
| Gross Margin | 49% | 58% | XXX | XXX | XXX |
| EBITDA | $45.2M | $41.6M | XXX | XXX | XXX |
| EBITDA Margin | 28% | 26% | XXX | XXX | XXX |
| Net Profit | $22.5M | $26.3M | XXX | XXX | XXX |
| Net Margin | 14% | 16% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Advanced Medical Solutions Group's stock price is GBP 2 (or $2).
Advanced Medical Solutions Group has current market cap of GBP 394M (or $507M), and EV of GBP 464M (or $597M).
See Advanced Medical Solutions Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $597M | $507M | XXX | XXX | XXX | XXX | $0.14 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Advanced Medical Solutions Group has market cap of $507M and EV of $597M.
Advanced Medical Solutions Group's trades at 2.4x LTM EV/Revenue multiple, and 10.8x LTM EBITDA.
Analysts estimate Advanced Medical Solutions Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Advanced Medical Solutions Group and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $597M | XXX | XXX | XXX |
| EV/Revenue | 3.7x | XXX | XXX | XXX |
| EV/EBITDA | 14.3x | XXX | XXX | XXX |
| P/E | 24.8x | XXX | XXX | XXX |
| P/E/Growth | 0.7x | XXX | XXX | XXX |
| EV/FCF | 185.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAdvanced Medical Solutions Group's NTM/LTM revenue growth is 21%
Advanced Medical Solutions Group's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Advanced Medical Solutions Group's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Advanced Medical Solutions Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Advanced Medical Solutions Group and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 26% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -8% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 47% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 40% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 41% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Advanced Medical Solutions Group acquired XXX companies to date.
Last acquisition by Advanced Medical Solutions Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Advanced Medical Solutions Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Advanced Medical Solutions Group founded? | Advanced Medical Solutions Group was founded in 1993. |
| Where is Advanced Medical Solutions Group headquartered? | Advanced Medical Solutions Group is headquartered in United Kingdom of Great Britain and Northern Ireland. |
| How many employees does Advanced Medical Solutions Group have? | As of today, Advanced Medical Solutions Group has 769 employees. |
| Who is the CEO of Advanced Medical Solutions Group? | Advanced Medical Solutions Group's CEO is Mr. Christopher Andrew Meredith. |
| Is Advanced Medical Solutions Group publicy listed? | Yes, Advanced Medical Solutions Group is a public company listed on LON. |
| What is the stock symbol of Advanced Medical Solutions Group? | Advanced Medical Solutions Group trades under AMS ticker. |
| When did Advanced Medical Solutions Group go public? | Advanced Medical Solutions Group went public in 2002. |
| Who are competitors of Advanced Medical Solutions Group? | Similar companies to Advanced Medical Solutions Group include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Advanced Medical Solutions Group? | Advanced Medical Solutions Group's current market cap is $507M |
| What is the current revenue of Advanced Medical Solutions Group? | Advanced Medical Solutions Group's last 12-month revenue is $248M. |
| What is the current EBITDA of Advanced Medical Solutions Group? | Advanced Medical Solutions Group's last 12-month EBITDA is $55.4M. |
| What is the current EV/Revenue multiple of Advanced Medical Solutions Group? | Current revenue multiple of Advanced Medical Solutions Group is 2.4x. |
| What is the current EV/EBITDA multiple of Advanced Medical Solutions Group? | Current EBITDA multiple of Advanced Medical Solutions Group is 10.8x. |
| What is the current revenue growth of Advanced Medical Solutions Group? | Advanced Medical Solutions Group revenue growth between 2023 and 2024 was 2%. |
| Is Advanced Medical Solutions Group profitable? | Yes, Advanced Medical Solutions Group is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
